These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33231843)

  • 41. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults.
    de Mol CL; Wong Y; van Pelt ED; Wokke B; Siepman T; Neuteboom RF; Hamann D; Hintzen RQ
    Mult Scler; 2020 Jun; 26(7):806-814. PubMed ID: 31094288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: A cohort study in China.
    Song H; Zhou H; Yang M; Xu Q; Sun M; Wei S
    J Neurol Sci; 2019 May; 400():83-89. PubMed ID: 30904690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rate of Leptomeningeal Enhancement in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis.
    Gadde JA; Wolf DS; Keller S; Gombolay GY
    J Child Neurol; 2021 Oct; 36(11):1042-1046. PubMed ID: 34547933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease.
    Hacohen Y; Rossor T; Mankad K; Chong W'; Lux A; Wassmer E; Lim M; Barkhof F; Ciccarelli O; Hemingway C
    Dev Med Child Neurol; 2018 Apr; 60(4):417-423. PubMed ID: 29288492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures.
    Gutman JM; Kupersmith M; Galetta S; Kister I
    J Neurol Sci; 2018 Apr; 387():170-173. PubMed ID: 29571858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
    Hacohen Y; Wong YY; Lechner C; Jurynczyk M; Wright S; Konuskan B; Kalser J; Poulat AL; Maurey H; Ganelin-Cohen E; Wassmer E; Hemingway C; Forsyth R; Hennes EM; Leite MI; Ciccarelli O; Anlar B; Hintzen R; Marignier R; Palace J; Baumann M; Rostásy K; Neuteboom R; Deiva K; Lim M
    JAMA Neurol; 2018 Apr; 75(4):478-487. PubMed ID: 29305608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
    Piccolo L; Woodhall M; Tackley G; Juryńczyk M; Kong Y; Domingos J; Gore R; Vincent A; Waters P; Leite MI; Palace J
    J Neurol; 2016 Feb; 263(2):370-379. PubMed ID: 26668077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
    Hennes EM; Baumann M; Schanda K; Anlar B; Bajer-Kornek B; Blaschek A; Brantner-Inthaler S; Diepold K; Eisenkölbl A; Gotwald T; Kuchukhidze G; Gruber-Sedlmayr U; Häusler M; Höftberger R; Karenfort M; Klein A; Koch J; Kraus V; Lechner C; Leiz S; Leypoldt F; Mader S; Marquard K; Poggenburg I; Pohl D; Pritsch M; Raucherzauner M; Schimmel M; Thiels C; Tibussek D; Vieker S; Zeches C; Berger T; Reindl M; Rostásy K;
    Neurology; 2017 Aug; 89(9):900-908. PubMed ID: 28768844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    Baumann M; Sahin K; Lechner C; Hennes EM; Schanda K; Mader S; Karenfort M; Selch C; Häusler M; Eisenkölbl A; Salandin M; Gruber-Sedlmayr U; Blaschek A; Kraus V; Leiz S; Finsterwalder J; Gotwald T; Kuchukhidze G; Berger T; Reindl M; Rostásy K
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):265-72. PubMed ID: 25121570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First Clinical Experience with Anti-myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis.
    Heckmann J; Todorova M; Müller S; Broser PJ; Sturm V
    Klin Monbl Augenheilkd; 2020 Apr; 237(4):458-463. PubMed ID: 32092775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.
    Cobo-Calvo A; Sepúlveda M; d'Indy H; Armangué T; Ruiz A; Maillart E; Papeix C; Audoin B; Zephir H; Biotti D; Ciron J; Durand-Dubief F; Collongues N; Ayrignac X; Labauge P; Thouvenot E; Montcuquet A; Deschamps R; Solà-Valls N; Llufriu S; Blanco Y; de Seze J; Vukusic S; Saiz A; Marignier R; ;
    J Neurol; 2019 Apr; 266(4):806-815. PubMed ID: 30607536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of myelin oligodendrocyte glycoprotein antibodies in pediatric onset multiple sclerosis.
    Solmaz I; Doran T; Yousefi M; Konuskan B; Oncel I; Vural A; Anlar B
    Mult Scler Relat Disord; 2022 Dec; 68():104097. PubMed ID: 35998500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early predictors of epilepsy and subsequent relapse in children with acute disseminated encephalomyelitis.
    Rossor T; Benetou C; Wright S; Duignan S; Lascelles K; Robinson R; Das K; Ciccarelli O; Wassmer E; Hemingway C; Lim M; Hacohen Y
    Mult Scler; 2020 Mar; 26(3):333-342. PubMed ID: 30730236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome.
    Pujari SS; Kulkarni RV; Nadgir DB; Ojha PK; Nagendra S; Aglave V; Nadgir RD; Sant H; Palasdeokar N; Nirhale S; Bandishti S
    Ann Indian Acad Neurol; 2021; 24(1):69-77. PubMed ID: 33911382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Anti-Myelin Oligodendrocyte Glycoprotein Antibodies in Paediatric Patients with Optic Neuritis].
    Tegetmeyer H; Merkenschlager A
    Klin Monbl Augenheilkd; 2017 Oct; 234(10):1243-1249. PubMed ID: 29025172
    [No Abstract]   [Full Text] [Related]  

  • 56. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
    Di Pauli F; Berger T
    Front Immunol; 2018; 9():2753. PubMed ID: 30555462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
    Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
    Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistent presence of the anti-myelin oligodendrocyte glycoprotein autoantibody in a pediatric case of acute disseminated encephalomyelitis followed by optic neuritis.
    Miyauchi A; Monden Y; Watanabe M; Sugie H; Morita M; Kezuka T; Momoi M; Yamagata T
    Neuropediatrics; 2014 Jun; 45(3):196-9. PubMed ID: 24610298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease.
    Pedreño M; Sepúlveda M; Armangué T; Sabater L; Martínez-Hernandez E; Arrambide G; Blanco Y; Llufriu S; Martínez-Lapiscina EH; Mulero P; Sola-Valls N; Ruiz-García R; Tintoré M; Dalmau J; Graus F; Saiz A
    Mult Scler Relat Disord; 2019 Feb; 28():230-234. PubMed ID: 30623863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.